Instrument Inactif

Communiqués Boule Diagnostics AB Nasdaq Stockholm

Actions

SE0000437402

Equipement et technologie médicale avancés

Communiqués

17/07	Boule Diagnostics Interim Report Q2 2026	AQ
18/06	Boule Diagnostics appoints new Chief Executive Officer	AQ
29/05	Interim CEO at Boule Diagnostics	AQ
13/05	Bulletin from the Annual General Meeting May 13, 2026 in Boule Diagnostics	AQ
28/04	Boule Diagnostics Interim Report Q1 2026	AQ
27/04	Boule Diagnostics – Invitation to presentation of the interim report Q1 2026	AQ
11/02	Boule Diagnostics Year-end report 2025	AQ
06/02	Boule Diagnostics – Invitation to presentation of the Q4 report 2025	AQ
21/01	Boule Diagnostics Renews and Expands a Global Supply Agreement	AQ
30/12	Boule Diagnostics appoints Michael af Winklerfelt as new CFO	AQ
22/12	Boule Diagnostics Selected as One of Three Providers in Nationwide Hematology Tender in Italy	AQ
05/12	Boule Diagnostics Announces CEO Transition as Organization Prepares for Next Chapter	AQ
21/11	Boule Diagnostics : Nomination Committee for the Annual General Meeting 2026	PU
21/11	Boule Diagnostics – Nomination Committee for the Annual General Meeting 2026	AQ
24/10/25	Boule Diagnostics Interim Report Q3 2025	AQ
20/10/25	Boule Diagnostics – Invitation to presentation of the interim report Q3 2025	AQ
13/10/25	Boule Diagnostics Announces CFO Departure for New Opportunity	AQ
18/07/25	Boule Diagnostics Interim Report Q2 2025	AQ
11/07/25	Boule Diagnostics : Invitation to presentation of the interim report Q2 2025	PU
11/07/25	Boule Diagnostics – Invitation to presentation of the interim report Q2 2025	AQ
07/05/25	Bulletin from the Annual General Meeting May 7, 2025 in Boule Diagnostics	AQ
28/04/25	Boule Diagnostics Interim Report Q1 2025	AQ
23/04/25	Boule Diagnostics : Invitation to presentation of the interim report Q1 2025	PU
23/04/25	Boule Diagnostics – Invitation to presentation of the interim report Q1 2025	AQ
08/05/24	Bulletin from the Annual General Meeting May 8, 2024 in Boule Diagnostics AB	AQ